The Impact of Prior Substance Use on Postoperative Outcomes Following Gender-Affirming Surgery
Open Access
- 21 August 2025
- journal article
- research article
- Published by MDPI AG in Therapeutics
- Vol. 2 (3) , 14
Abstract
Background/Objectives: Gender-affirming surgery (GAS) is associated with improved mental health outcomes in transgender and gender-diverse (TGD) individuals. However, TGD populations experience disproportionately high rates of substance use disorders (SUDs), which are established risk factors for surgical complications. Despite this, the relationship between preoperative SUDs and postoperative outcomes following GAS has not been studied. Our objective was to evaluate how specific SUD subtypes, including tobacco, alcohol, and cannabis, impact short- and medium-term postoperative complications following GAS. Methods: A retrospective cohort study was conducted using the TriNetX Research Network, which includes de-identified electronic health records from over 100 million U.S. patients. Adults with documented gender dysphoria who underwent GAS between April 2015 and April 2025 were included. Patients were divided into four groups: no SUD, tobacco use, alcohol use, and cannabis use. Propensity score matching was used to control for demographic variables. Postoperative complications were assessed at 30 days and 6 months. Results: Alcohol use was significantly associated with increased rates of delayed wound healing, wound dehiscence, gastrointestinal symptoms, and postoperative pain at both 30 days and 6 months. Cannabis use was linked to higher rates of wound dehiscence, infections, GI symptoms, and pain. Tobacco use showed the broadest impact, significantly associated with nearly all complications measured except pain at 30 days. These associations persisted at six months. Conclusions: This is the first study to quantify the relationship between substance use and GAS outcomes. Preoperative use of tobacco, alcohol, and cannabis was independently associated with increased postoperative complications. These findings underscore the need for systematic preoperative screening and the development of SUD-specific perioperative care pathways to improve outcomes and advance equity in surgical care for TGD patients.Keywords
Funding Information
- National Center for Advancing Translational Sciences (UL1 TR001439, 1 D34HP49234-01-00)
- Department of Health and Human Services, Health Resources and Services Administration (UL1 TR001439, 1 D34HP49234-01-00)
This publication has 29 references indexed in Scilit:
- Lessons learned from implementing a diversity, equity, and inclusion curriculum for health research professionals at a large academic research institutionJournal of Clinical and Translational Science, 2024
- Differences in Alcohol and Other Drug Use and Dependence Between Transgender and Cisgender Participants from the 2018 Global Drug SurveyLGBT Health, 2022
- Prevalence and Co-occurrence of Alcohol, Nicotine, and Other Substance Use Disorder Diagnoses Among US Transgender and Cisgender AdultsJAMA Network Open, 2021
- The Effects of Opioid Use on Thromboembolic Complications, Readmission Rates, and 90-Day Episode of Care Costs After Total Hip ArthroplastyThe Journal of Arthroplasty, 2020
- A Systematic Review of Interventions to Reduce Problematic Substance Use Among Transgender Individuals: A Call to ActionTransgender Health, 2017
- Transgender Use of Cigarettes, Cigars, and E-Cigarettes in a National StudyAmerican Journal of Preventive Medicine, 2017
- Substance Use to Cope with Stigma in Healthcare Among U.S. Female-to-Male Trans Masculine AdultsLGBT Health, 2015
- Substance use and treatment of substance use disorders in a community sample of transgender adultsDrug and Alcohol Dependence, 2015
- Characteristics of transgender individuals entering substance abuse treatmentAddictive Behaviors, 2014
- Midline CleftArchives of Facial Plastic Surgery, 1999